Related Experiment Videos
Low-dose aprotinin in cardiac operations
R Haddad1, C Kesrouani, W Nasr
1Department of Surgery, American University of Beirut-Medical Center, Beirut, Lebanon. mrsmith@dm.net.lb
Le Journal Medical Libanais. the Lebanese Medical Journal
|March 28, 2001
Summary
Low-dose aprotinin significantly reduces bleeding and transfusion needs in cardiac surgery patients taking aspirin. This finding is crucial for improving patient outcomes during heart operations.
Area of Science:
- Cardiology
- Anesthesiology
- Hematology
Background:
- Aspirin is commonly prescribed for heart disease patients.
- Aspirin use increases bleeding risk during cardiac surgery due to platelet dysfunction.
Purpose of the Study:
- To evaluate the effectiveness of low-dose aprotinin in reducing blood loss and transfusion requirements.
- To assess aprotinin's efficacy in patients undergoing cardiac surgery who are also taking aspirin.
Main Methods:
- Retrospective analysis of 82 open-heart surgery patients.
- Patients categorized into three groups: no aspirin/aprotinin, aspirin + aprotinin, and aspirin only.
- Primary outcomes measured: total blood loss and transfusion volume.
Main Results:
- Aprotinin group showed significantly lower total blood loss (359 ml) compared to control groups (527 ml and 628 ml).
- Bleeding rates were significantly reduced in the aprotinin group (17.2 ml/hr).
- Transfusion volumes and prevalence were lower in patients receiving aprotinin.
Conclusions:
- Low-dose aprotinin is effective in minimizing blood loss during cardiac surgery.
- Aprotinin reduces the need for blood transfusions in aspirin-treated patients undergoing heart operations.